Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#1392 most reported symptom for this vaccine
Gingival bleeding has been reported 7 times in association with Hepatitis B (Engerix-B) vaccination in VAERS. This represents 0.0% of all 73,280 reports for this vaccine.
Among these reports, 1 mentioned death (14.29%) and 3 involved hospitalization (42.9%).
Gingival bleeding is the #1392 most frequently reported symptom for Hepatitis B (Engerix-B) out of 2382 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 7 reports of Gingival bleeding after Hepatitis B (Engerix-B) vaccination may seem alarming, but context is critical.
The 14.29% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.